Literature DB >> 10954577

Activation of the interferon-inducible 2'-5'-oligoadenylate synthetase gene by hepatitis C virus core protein.

A Naganuma1, A Nozaki, T Tanaka, K Sugiyama, H Takagi, M Mori, K Shimotohno, N Kato.   

Abstract

The effects of hepatitis C virus (HCV) proteins on several signal transduction pathways in human nonneoplastic hepatocyte PH5CH8 cells were investigated using expression vectors encoding HCV proteins derived from HCV-infected human nonneoplastic cultured T-lymphocyte and hepatocyte cells (MT-2C and PH5CH7), which could support HCV replication. The amino acid sequences of HCV proteins obtained from HCV-infected human cells were identical or very close to the consensus sequences of the proteins derived from the original inoculum used for HCV infection. During the course of the study, we found that HCV core protein specifically activated the 40/46-kDa 2'-5'-oligoadenylate synthetase (2'-5'-OAS) gene promoter in a dose-dependent manner in different human hepatocyte cell lines (PH5CH8, HepG2, and PLC/PRF/5). We also found that the activation by core protein was further enhanced in the cells treated with alpha interferon. The expression of E1 or E2 envelope protein or nonstructural NS5A protein did not activate the 2'-5'-OAS gene promoter. We demonstrated that the activation by core protein in the hepatocyte cells was suppressed by antisense RNA complementary to core-encoding RNA. Deletion mutant analysis of core protein and deletion analysis of the 2'-5'-OAS gene promoter have been performed. Finally, we demonstrated that the activation of the 2'-5'-OAS gene occurred at the transcriptional level and furthermore demonstrated that the endogenous 2'-5'-OAS gene was also activated by core protein. This is the first report to show that a viral protein activated the 2'-5'-OAS gene.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10954577      PMCID: PMC116387          DOI: 10.1128/jvi.74.18.8744-8750.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis.

Authors:  N Zhu; A Khoshnan; R Schneider; M Matsumoto; G Dennert; C Ware; M M Lai
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme.

Authors:  C Rivas; J Gil; Z Mĕlková; M Esteban; M Díaz-Guerra
Journal:  Virology       Date:  1998-04-10       Impact factor: 3.616

3.  Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype.

Authors:  R B Ray; L M Lagging; K Meyer; R Ray
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

4.  Transcriptional repression of p53 promoter by hepatitis C virus core protein.

Authors:  R B Ray; R Steele; K Meyer; R Ray
Journal:  J Biol Chem       Date:  1997-04-25       Impact factor: 5.157

5.  Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene.

Authors:  J Chang; S H Yang; Y G Cho; S B Hwang; Y S Hahn; Y C Sung
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

6.  Suppression of actinomycin D-induced apoptosis by the NS3 protein of hepatitis C virus.

Authors:  T Fujita; S Ishido; S Muramatsu; M Itoh; H Hotta
Journal:  Biochem Biophys Res Commun       Date:  1996-12-24       Impact factor: 3.575

7.  Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein.

Authors:  R B Ray; L M Lagging; K Meyer; R Steele; R Ray
Journal:  Virus Res       Date:  1995-08       Impact factor: 3.303

8.  Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2.

Authors:  T Mizutani; N Kato; S Saito; M Ikeda; K Sugiyama; K Shimotohno
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

9.  A novel sequence found at the 3' terminus of hepatitis C virus genome.

Authors:  T Tanaka; N Kato; M J Cho; K Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  1995-10-13       Impact factor: 3.575

10.  Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator.

Authors:  N Kato; K H Lan; S K Ono-Nita; Y Shiratori; M Omata
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

View more
  13 in total

Review 1.  Viral determinants of resistance to treatment in patients with hepatitis C.

Authors:  Anette Wohnsland; Wolf Peter Hofmann; Christoph Sarrazin
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

2.  Repression of interferon regulatory factor 1 by hepatitis C virus core protein results in inhibition of antiviral and immunomodulatory genes.

Authors:  Anna R Ciccaglione; Emilia Stellacci; Cinzia Marcantonio; Valentina Muto; Michele Equestre; Giulia Marsili; Maria Rapicetta; Angela Battistini
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

3.  Genotypic Regulation of Type I Interferon Induction Pathways by Frameshift (F) Proteins of Hepatitis C Virus.

Authors:  Yi-Ting Lai; Yih-Mei Liou; Fu Hsin; Helene Minyi Liu
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

4.  Proapoptotic and pronecrosis effect of different truncated hepatitis C virus core proteins.

Authors:  Xue-bing Yan; Zhi Chen; Dong-hui Luo; Xiao-yan Xu; Wei Wu; Lin-fu Zhou
Journal:  J Zhejiang Univ Sci B       Date:  2005-04       Impact factor: 3.066

Review 5.  The hepatitis C virus persistence: how to evade the immune system?

Authors:  Nicole Pavio; Michael M C Lai
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

6.  OAS1 polymorphisms are associated with susceptibility to West Nile encephalitis in horses.

Authors:  Jonathan J Rios; Joann G W Fleming; Uneeda K Bryant; Craig N Carter; John C Huber; Maureen T Long; Thomas E Spencer; David L Adelson
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

7.  Specific activation of 2'-5'oligoadenylate synthetase gene promoter by hepatitis C virus-core protein: a potential for developing hepatitis C virus targeting gene therapy.

Authors:  Ying Wang; Shan-Shan Mao; Qiong-Qiong He; Yuan Zi; Ji-Fang Wen; De-Yun Feng
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

8.  Molecular Cloning and Identification of the 2'-5' Oligoadenylate Synthetase 2 Gene in Chinese Domestic Pigs Through Bioinformatics Analysis, and Determination of Its Antiviral Activity Against Porcine Reproductive and Respiratory Syndrome Virus Infection.

Authors:  Ruining Wang; Hongfang Ma; Yinfeng Kang; Cunfa Li; Huawei Li; Erqin Zhang; Pengchao Ji; Jian He; Mengmeng Zhao
Journal:  Indian J Microbiol       Date:  2018-04-26       Impact factor: 2.461

9.  Transcriptional activation of interferon-stimulated genes but not of cytokine genes after primary infection of rhesus macaques with dengue virus type 1.

Authors:  Carlos A Sariol; Jorge L Muñoz-Jordán; Kristina Abel; Lymarie C Rosado; Petraleigh Pantoja; Luis Giavedoni; Idia Vanessa Rodriguez; Laura J White; Melween Martínez; Teresa Arana; Edmundo N Kraiselburd
Journal:  Clin Vaccine Immunol       Date:  2007-04-11

10.  Involvement of PKR and RNase L in translational control and induction of apoptosis after Hepatitis C polyprotein expression from a vaccinia virus recombinant.

Authors:  Carmen E Gómez; Andrée Marie Vandermeeren; María Angel García; Elena Domingo-Gil; Mariano Esteban
Journal:  Virol J       Date:  2005-09-12       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.